Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.

Wang, Lili; Stadlbauer, Birgit; Lyu, Chen; Buchner, Alexander; Pohla, Heike

Wang, Lili; Stadlbauer, Birgit; Lyu, Chen; Buchner, Alexander; Pohla, Heike.

Afiliação

Wang L; Tumor Immunology Laboratory, LIFE Center, LMU Klinikum, University Munich Germany.
Stadlbauer B; Tumor Immunology Laboratory, LIFE Center, LMU Klinikum, University Munich Germany.
Lyu C; Department of Urology, LMU Klinikum, University Munich Germany.
Buchner A; Tumor Immunology Laboratory, LIFE Center, LMU Klinikum, University Munich Germany.
Pohla H; Tumor Immunology Laboratory, LIFE Center, LMU Klinikum, University Munich Germany.

Am J Cancer Res ; 10(11): 3784-3800, 2020.

Article em En | MEDLINE | ID: mdl-33294267